Skip to main content
. 2017 Oct-Dec;21(4):e2017.00061. doi: 10.4293/JSLS.2017.00061

Table 1.

Patient Characteristics

All liver Resections Laparoscopic Resection Open Resection P*
Number 1525** 40 80
Age, years (median, range) 63 (16–93) 60 (20–83) 62,5 (24–82) 0.08
Sex, female/male, n 656/829 19/21 29/51 0.24
BMI, kg/m2, mean (SD) 26.5 (4.9) 28.3 (5.8) 27.5 (5.6) 0.62
ASA score, n (%) 0.05
    I 22 (1.4) 3 (7.5) 0
    II 741 (48.6) 23 (57.5) 41 (51.3)
    III 701 (46) 14 (35) 38 (47.5)
    IV 21 (1.4) 0 1 (1.3)
Liver cirrhosis, n (%) 147 (9.6) 8 (20) 16 (20) 1.0
Tumor size, cm (median, range) 4.4 (0.5–10.5) 4.35 (0.5–13) 0.64
Biology (benign/malignant) 14/26 7/73 0.001
Tumor type, n 0.007
    Adenoma 18 6 2
    FNH 33 8 4
    HCC 232 11 22
    CCC 179 6
    CRC mets 558 11 32
    Endocrine mets 33 4 13
    Non-CRC/nonendocrine mets 121
    Klatskin tumor 107
    Gallbladder cancer 34
    Others 170
Type of resection, n (%) 0.99
    Left lateral sectionectomy 131 (8.8) 16 (40%) 32 (40%)
    Segmentectomy 438 (29.5%) 23 (57.5%) 46 (57.5%)
    Atypical resection 392 (26.4%) 1 (2.5%) 2 (2.5%)
    Hemihepatectomy (extended) 524 (35.3%)
Iwate score, median (range) 5 (4–9) 5 (4–8) 0.76
*

Laparoscopic versus open resection;

**

1485 fully evaluable. CCC, cholangiocellular carcinoma; mets, metastases.